论文部分内容阅读
随着我国人民生活水平的提高,冠状动脉粥样硬化性心脏病(简称冠心病)已成为造成我国人群死亡的第三大疾患[1]。现已证实血脂代谢异常是其主要发病机制。现将30例高脂血症患者服用常规剂量辛伐他丁(舒降之)的疗效及不良反应结果报告如下。1资料与方法1.1一般资料:30例高脂血症为
With the improvement of living standards in our country, coronary atherosclerotic heart disease (referred to as coronary heart disease) has become the third largest cause of death of our population [1]. It has been confirmed that dyslipidemia is its main pathogenesis. Now 30 cases of patients with hyperlipidemia taking conventional dose of simvastatin (SHR) efficacy and adverse reactions reported below. 1 Materials and Methods 1.1 General Information: 30 cases of hyperlipidemia